Researchers continue to examine how GLP-1s might affect a persons health beyond type 2 diabetes management and weight loss
Morales-Barrera R, Rodriguez CS, and Gonzalez M, et al (2019) Impact of immune-related adverse events on survival in patients with metastastic urothelial carcinoma treated with immune-checkpoint inhibitors J Clin Oncol 37 (15_suppl) 4531 86
"You know, I approached playing the dumbest blonde in America intellectually," she said
She was so overweight she had to sign a waiver to say she might not make it through a vital operation
doi: 10.1007/s00430-008-0105-2 175 LiJ.PfefferS
Originally designed to treat type 2 diabetes, these medications are now approved for weight management due to their impressive results in promoting healthy, sustainable weight loss